Impact of Mitral Valve Regurgitation Evaluated by Intraoperative Transesophageal Echocardiography on Long-Term Outcomes After Coronary Artery Bypass Grafting

Background—It is unclear if mild or moderate mitral valve regurgitation (MR) should be repaired at the time of coronary artery bypass grafting (CABG). We sought to determine the long-term effect of uncorrected MR, measured by intraoperative transesophageal echocardiography (TEE), in CABG patients. Methods and Results—Between May 1999 and September 2003, data were gathered for 3264 consecutive patients who underwent isolated CABG and had MR graded by intraoperative TEE. MR was graded on the following 5 levels: none, trace, mild, moderate, and severe. Patients who had severe MR or who underwent mitral valve surgery were eliminated from the analysis. The remaining patients were combined into the following 3 groups: none or trace, mild, and moderate MR. Preoperative and follow-up data were 99% complete. The median length of follow-up was 3.0 years. Multivariable analysis controlling for important preoperative risk factors was performed to determine predictors of death and death/hospitalization for heart failure. Increasing MR was a risk factor for death [hazard ratio (HR), 1.44; P<0.001] and death/heart failure hospitalization (HR, 1.34; P<0.01). When patients with moderate MR were eliminated from the analysis, mild MR was a risk factor for death (HR, 1.34; P=0.011) and death/hospitalization for heart failure (HR, 1.34; P<0.001). Conclusions—Even mild MR, identified by intraoperative TEE, predicts worse outcomes after CABG. Revascularization alone did not eliminate the negative long-term effects of mild MR. CABG patients with uncorrected mild or moderate MR are at increased risk for death and heart-failure hospitalization; consideration for surgical repair or more aggressive medical management and follow-up is warranted.

[1]  J. J. Griffin,et al.  Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. , 2004, Journal of the American College of Cardiology.

[2]  N. Desai,et al.  Late outcomes in patients with uncorrected mild to moderate mitral regurgitation at the time of isolated coronary artery bypass grafting. , 2004, The Journal of thoracic and cardiovascular surgery.

[3]  K. Anstrom,et al.  Survival After Coronary Revascularization, With and Without Mitral Valve Surgery, in Patients With Ischemic Mitral Regurgitation , 2003, Circulation.

[4]  E. Hannan,et al.  Predictors of readmission for complications of coronary artery bypass graft surgery. , 2003, JAMA.

[5]  Robert J Cody,et al.  Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. , 2002, American heart journal.

[6]  S. Ellis,et al.  Impact of mitral regurgitation on long-term survival after percutaneous coronary intervention. , 2002, The American journal of cardiology.

[7]  K. Bailey,et al.  Ischemic Mitral Regurgitation: Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment , 2001, Circulation.

[8]  C. Kramer,et al.  Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography. , 2000, The American journal of cardiology.

[9]  W J Stewart,et al.  ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certifi , 1999, Anesthesia and analgesia.

[10]  W J Stewart,et al.  ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certifi , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[11]  G. Lamas,et al.  Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. , 1997, Circulation.

[12]  E L Hannan,et al.  Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. , 1996, Journal of the American College of Cardiology.

[13]  R. Dion Ischemic mitral regurgitation: when and how should it be corrected? , 1993, The Journal of heart valve disease.

[14]  R. Califf,et al.  Outcome of Patients Sustaining Acute Ischemic Mitral Regurgitation during Myocardial Infarction , 1992, Annals of Internal Medicine.

[15]  R H Jones,et al.  Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. , 1991, Circulation.

[16]  J. Kisslo,et al.  Intraoperative Transesophageal Doppler Color Flow Imaging Used to Guide Patient Selection and Operative Treatment of Ischemic Mitral Regurgitation , 1991, Circulation.

[17]  A. Jaffe,et al.  Prognostic significance of mitral regurgitation in acute myocardial infarction. The MILIS Study Group. , 1990, The American journal of cardiology.

[18]  J. Kisslo,et al.  The utility of transesophageal echocardiography and Doppler color flow imaging in patients undergoing cardiac valve surgery. , 1990, Journal of the American College of Cardiology.

[19]  E. Jones,et al.  Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone. , 1988, The Journal of thoracic and cardiovascular surgery.

[20]  E. Cook,et al.  Long-term survival of more than 2,000 patients after coronary artery bypass grafting. , 1986, The American journal of cardiology.

[21]  F. Harrell,et al.  Survival in medically treated coronary artery disease. , 1979, Circulation.

[22]  P. Grayburn,et al.  Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. , 1997, Circulation.

[23]  M. Cowan,et al.  American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.